ArticleGenome medicine2026
Cumulative cgMLST provides increased discrimination of nested phylogenetic groups.
Article in Genome medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cumulative cgMLST provides increased discrimination of nested phylogenetic groups.Genome medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCore genome multilocus sequence typing (cgMLST) is a powerful method for bacterial strain genotyping. However, the size of the core genome decreases as the phylogenetic breadth of the target group increases, reducing discriminatory power. To overcome this discrimination/applicability tradeoff, here we developed a cumulative cgMLST approach, where sets of core loci conserved within nested phylogenetic entities are added. We illustrate this approach using the Klebsiella pneumoniae species complex (KpSC), for which a widely used cgMLST scheme (KpSC-cgMLST) comprises only 629 genes.
methodsWe created non-redundant cgMLST schemes for the individual species K. pneumoniae sensu stricto (Kpn-cgMLST scheme), and its multidrug resistant sublineages (SLs) SL147 and SL307. To extract core genes, we used 37,874 genome assemblies originating from over 80 countries worldwide. A methodology was set to filter redundant loci before importing them into the genotyping tool BIGSdb, where they were combined into schemes together with preexisting loci conserved at higher phylogenetic levels. The performance of the cumulative cgMLST schemes was evaluated on previously published datasets and on novel data from an inter-hospital outbreak of SL307.
resultsThe Kpn-cgMLST, SL147 and SL307 schemes comprise 2752, 852, and 947 additional loci, respectively. The mean allele call rate of the novel loci was > 99% in the validation datasets. Compared to the KpSC scheme used alone, pairwise allelic distances among isolates increased on average 5.6-fold using the Kpn scheme, and further by 1.2-fold and 1.3-fold using the SL147 and SL307 schemes, respectively. We demonstrated the added value of this increased discriminatory power for epidemiological analyses and observed a level of discrimination that approaches that of whole-genome single nucleotide polymorphism analysis.
conclusionsThe cumulative cgMLST strategy combines broad phylogenetic applicability and nearly complete genotyping resolution, expanding the utility of this harmonized approach for genomic epidemiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.